Cancer Investigation
Volume 39, 2021 - Issue 5
Open access
2,841
Views
0
CrossRef citations to date
0
Altmetric
Research Article
Efficacy and Safety of CDK4/6 Inhibitors Combined with Endocrine Therapy in HR+/HER-2− ABC Patients: A Systematic Review and Meta-Analysis
Yongyan Lia Department of Oncology, Beijing Pinggu District Hospital, Beijing, China
, Li Lib Department of Oncology, Beijing Friendship Hospital, Capital Medical University, Beijing, China
, Qi Dub Department of Oncology, Beijing Friendship Hospital, Capital Medical University, Beijing, China
, Yongfu Lic Department of Oncology, Second Affiliated Hospital of Hainan Medical University, Haikou, China
, Haifang Yanga Department of Oncology, Beijing Pinggu District Hospital, Beijing, China
& Qin Lib Department of Oncology, Beijing Friendship Hospital, Capital Medical University, Beijing, ChinaCorrespondence[email protected]
https://orcid.org/0000-0002-2470-6089
Pages 369-378
|
Received 09 Sep 2020, Accepted 25 Mar 2021, Published online: 22 Apr 2021
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.